[Level of Knowledge and Action on Lipaemia Among Spanish Primary and Specialist Care Doctors. Press Cholesterol Study]

Overview

Journal Aten Primaria

Specialty Public Health

Date 2006 Sep 19

PMID 16978557

Authors

Jose Abellan Aleman

Mariano Leal Hernandez

Antonio Martinez Pastor

Fernando Hernandez Menarguez

Jose Antonio Garcia-Galbis Marin

Purificacion Jara Gomez

Affiliations

Soon will be listed here.

Abstract

Objectives: To find the level of knowledge, the guidelines for action and the monitoring of lipaemia by Spanish primary care and specialist doctors.

Design And Intervention: A self-defined questionnaire of 12 items was designed. Data on the population treated and the subjective evaluation of objectives, and on the management and monitoring of lipid parameters were filled in.

Setting And Participants: A total of 1998 doctors from the whole of Spain took part; 68.8% of the doctors interviewed worked in primary health care and 30.2% in specialist centres or hospitals.

Results: A 91% of the doctors said they followed international consensus on monitoring lipaemia. The most commonly used objective therapeutic parameter for treating lipaemia was LDL-cholesterol (83%), followed by total cholesterol (62%), HDL-cholesterol (56%) and triglycerides (51%). If the patient's lipaemia was well controlled, then 21.8% of doctors reduced the doses of lipid-lowerers. In general terms, no great differences were appreciated between the criteria followed by PC and by specialist doctors.

Conclusions: The criteria for action on lipaemia could be improved. There are no important differences of view or action in clinical and therapeutic criteria for Lipaemia cases between PC and specialist doctors.

References

McDermid G, Lang C, Doran J, Struthers A . Physicians' attitudes to the treatment of elevated serum cholesterol. J R Coll Physicians Lond. 1990; 24(4):271-6. PMC: 5387534. View

Brotons C, Server M, Pinto X, Roura P . [Impact of consensus conferences of hypercholesterolemia and hypertension in Spain]. Med Clin (Barc). 1997; 108(1):9-15. View

Pearson T, Blair S, Daniels S, Eckel R, Fair J, Fortmann S . AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association.... Circulation. 2002; 106(3):388-91. DOI: 10.1161/01.cir.0000020190.45892.75. View

Villar Alvarez F, Banegas Banegas J, Rodriguez Artalejo F, DEL REY CALERO J . [Cardiovascular mortality in Spain and its autonomous communities (1975-1992)]. Med Clin (Barc). 1998; 110(9):321-7. View

Gomez-Gerique J, Gutierrez-Fuentes J, Montoya M, Porres A, Rueda A, Avellaneda A . [Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group]. Med Clin (Barc). 2000; 113(19):730-5. View

Martinez G, Quinones S, Castillo L, Ramos A, Avellana E, Ciurana R . [Adequacy of the pharmacologic treatment to the recommendations of a performance protocol in hypercholesterolemia in primary care]. Aten Primaria. 1996; 18(4):176-81. View

Celentano A, Panico S, Palmieri V, Guillaro B, Brancati C, Di Palma Esposito N . Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). Nutr Metab Cardiovasc Dis. 2003; 13(4):211-7. DOI: 10.1016/s0939-4753(03)80013-3. View

Brea Hernando A, Villar Arias M, Mosquera Lozano J, Ramirez Aleson M . [Treatment of hyperlipemia: opinions of primary care physicians of the La Rioja region]. Med Clin (Barc). 1996; 106(11):409-13. View

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

10.

Garcia Closas R, Serra Majem L, Chacon Castro P, Olmos Castellvell M, Ribas Barba L, Salleras Sanmarti L . [Distribution of blood lipids in a representative sample of the adult population of Catalonia. Research Group on Assessment of the Nutritional Status of the Catalonian Population: Biochemical Assessment]. Med Clin (Barc). 1999; 113(1):6-12. View

11.

Bowling A, Redfern J . The process of outpatient referral and care: the experiences and views of patients, their general practitioners, and specialists. Br J Gen Pract. 2000; 50(451):116-20. PMC: 1313628. View

12.

Bradley A, Elliott J, White H . Attitudes and practice of New Zealand doctors in the management of patients with dyslipidaemia. N Z Med J. 1993; 106(958):243-7. View

13.

Alonso Cerezo C, Simon Martin J, Fernandez Jimenez G, Rivera Franco J . [Attitude of primary care doctors to follow-up dyslipidemias]. Aten Primaria. 2004; 33(6):320-5. PMC: 7676071. DOI: 10.1016/s0212-6567(04)70800-8. View

14.

. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica. 2000; 74(3):215-53. View

15.

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J . European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24(17):1601-10. DOI: 10.1016/s0195-668x(03)00347-6. View